Can we predict chemo risks for seniors? new study seeks answers
NCT ID NCT01472094
First seen Nov 10, 2025 · Last updated May 18, 2026 · Updated 29 times
Summary
This study aims to create a model that predicts which older adults (65+) with early-stage breast cancer are more likely to experience serious side effects from chemotherapy. Researchers will look at clinical factors and blood markers to understand why some patients have more toxicity. The goal is to help doctors personalize treatment and reduce harm. The study involves 700 participants and is not currently recruiting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Case Western Reserve University
Cleveland, Ohio, 44106, United States
-
City of Hope Medical Center
Duarte, California, 91010, United States
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19111, United States
-
Hofstra-North-LIJ Cancer Institute
New Hyde Park, New York, 11042, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Memorial Sloan-Kettering Cancer Center
New York, New York, 10065, United States
-
Rhode Island Hospital
Providence, Rhode Island, 02903, United States
-
Roswell Park Cancer Institute
Buffalo, New York, 14263, United States
-
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
-
University of Chicago
Chicago, Illinois, 60637, United States
-
University of North Carolina
Chapel Hill, North Carolina, 27514, United States
-
University of Rochester Medical Center
Rochester, New York, 14642, United States
-
University of Virginia Health System
Charlottesville, Virginia, 22903, United States
-
Wake Forest University
Winston-Salem, North Carolina, 27106, United States
-
Washington University St. Louis
St Louis, Missouri, 63110, United States
-
Yale University
New Haven, Connecticut, 06510, United States
Conditions
Explore the condition pages connected to this study.